Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93



Montano M, Bhasin S, D'Aquila RT, Erlandson KM, Evans WJ, Funderburg NT, Justice A, Ndhlovu LC, Ojikutu B, Pahor M, Pahwa S, Ryan AS, Schrack J, Schultz M, Sebastiani P, Sinclair DA, Tripp J, Walker B, Womack J, Yung R, Reeves RK.

AIDS Res Hum Retroviruses. 2019 Aug 28. doi: 10.1089/AID.2019.0130. [Epub ahead of print]


Efficacy and Safety of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, for the Treatment of Keratoconjunctivitis Sicca: Pooled Analysis of a Phase 2b/3 and Phase 3 Study.

Sheppard J, Kannarr S, Luchs J, Malhotra R, Justice A, Ogundele A, Darby C, Bacharach J.

Eye Contact Lens. 2019 Jul 25. doi: 10.1097/ICL.0000000000000636. [Epub ahead of print]


Effect estimates in randomized trials and observational studies: comparing apples with apples.

Lodi S, Phillips A, Lundgren J, Logan R, Sharma S, Cole SR, Babiker A, Law M, Chu H, Byrne D, Horban A, Sterne JAC, Porter K, Sabin C, Costagliola D, Abgrall S, Gill J, Touloumi G, Pacheco AG, van Sighem A, Reiss P, Bucher HC, Montoliu Giménez A, Jarrin I, Wittkop L, Meyer L, Perez-Hoyos S, Justice A, Neaton JD, Hernán MA; INSIGHT START Study Group and the HIV-CAUSAL Collaboration.

Am J Epidemiol. 2019 May 7. pii: kwz100. doi: 10.1093/aje/kwz100. [Epub ahead of print]


A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers.

Karpecki PM, Weiss SL, Kramer WG, O'Connor P, Evans D, Johnston J, Jasper AL, Justice A, Ogundele AB, Devries D.

Clin Ophthalmol. 2019 Apr 5;13:591-596. doi: 10.2147/OPTH.S187945. eCollection 2019.


A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease.

Goldberg DF, Malhotra RP, Schechter BA, Justice A, Weiss SL, Sheppard JD.

Ophthalmology. 2019 Sep;126(9):1230-1237. doi: 10.1016/j.ophtha.2019.03.050. Epub 2019 Apr 6.


Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals.

Caniglia EC, Robins JM, Cain LE, Sabin C, Logan R, Abgrall S, Mugavero MJ, Hernández-Díaz S, Meyer L, Seng R, Drozd DR, Seage Iii GR, Bonnet F, Le Marec F, Moore RD, Reiss P, van Sighem A, Mathews WC, Jarrín I, Alejos B, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Gill J, Pacheco A, Grinsztejn B, Napravnik S, Jose S, Phillips A, Justice A, Tate J, Bucher HC, Egger M, Furrer H, Miro JM, Casabona J, Porter K, Touloumi G, Crane H, Costagliola D, Saag M, Hernán MA.

Stat Med. 2019 Jun 15;38(13):2428-2446. doi: 10.1002/sim.8120. Epub 2019 Mar 18.


Predictors of timely opioid agonist treatment initiation among veterans with and without HIV.

Wyse JJ, Robbins JL, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Gaither JR, Gordon K, Skanderson M, Barry DT, Crystal S, Justice A, Kraemer KL.

Drug Alcohol Depend. 2019 May 1;198:70-75. doi: 10.1016/j.drugalcdep.2019.01.038. Epub 2019 Mar 9.


Podocyte histone deacetylase activity regulates murine and human glomerular diseases.

Inoue K, Gan G, Ciarleglio M, Zhang Y, Tian X, Pedigo CE, Cavanaugh C, Tate J, Wang Y, Cross E, Groener M, Chai N, Wang Z, Justice A, Zhang Z, Parikh CR, Wilson FP, Ishibe S.

J Clin Invest. 2019 Mar 1;129(3):1295-1313. doi: 10.1172/JCI124030. Epub 2019 Feb 18.


Colonic metastasis from infiltrating ductal breast carcinoma in a male patient: A case report.

Jones A, Kocher MR, Justice A, Navarro F.

Int J Surg Case Rep. 2019;54:34-38. doi: 10.1016/j.ijscr.2018.11.019. Epub 2018 Nov 16.


Causal modeling in a multi-omic setting: insights from GAW20.

Auerbach J, Howey R, Jiang L, Justice A, Li L, Oualkacha K, Sayols-Baixeras S, Aslibekyan SW.

BMC Genet. 2018 Sep 17;19(Suppl 1):74. doi: 10.1186/s12863-018-0645-4.


Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis.

Grover S, Desir F, Jing Y, Bhatia RK, Trifiletti DM, Swisher-McClure S, Kobie J, Moore RD, Rabkin CS, Silverberg MJ, Salters K, Mathews WC, Gill MJ, Thorne JE, Castilho J, Kitahata MM, Justice A, Horberg MA, Achenbach CJ, Mayor AM, Althoff KN; North American AIDS Cohort Collaboration on Research and Design.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):421-429. doi: 10.1097/QAI.0000000000001842.


Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.

Hawkins KL, Gordon KS, Levin MJ, Weinberg A, Battaglia C, Rodriguez-Barradas MC, Brown ST, Rimland D, Justice A, Tate J, Erlandson KM; VACS Project Team.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):527-533. doi: 10.1097/QAI.0000000000001846.


A unique case report of jejunoileal bypass reversal with review of the literature.

Justice A, Keilani Z, Tribble J.

Int J Surg Case Rep. 2018;50:88-91. doi: 10.1016/j.ijscr.2018.07.028. Epub 2018 Jul 31.


In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits.

Sheppard JD, Cockrum PC, Justice A, Jasek MC.

Ophthalmol Ther. 2018 Jun;7(1):157-165. doi: 10.1007/s40123-018-0130-1. Epub 2018 May 14. Erratum in: Ophthalmol Ther. 2019 Feb 19;:.


Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV-Positive and HIV-Negative Individuals in VACS (Veterans Aging Cohort Study).

Marconi VC, Duncan MS, So-Armah K, Re VL 3rd, Lim JK, Butt AA, Goetz MB, Rodriguez-Barradas MC, Alcorn CW, Lennox J, Beckman JA, Justice A, Freiberg M.

J Am Heart Assoc. 2018 May 2;7(10). pii: e007792. doi: 10.1161/JAHA.117.007792.


Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl.

Kong CY, Sigel K, Criss SD, Sheehan DF, Triplette M, Silverberg MJ, Henschke CI, Justice A, Braithwaite RS, Wisnivesky J, Crothers K.

AIDS. 2018 Jun 19;32(10):1333-1342. doi: 10.1097/QAD.0000000000001818.


Correction to: Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment.

Halpin SN, Carruth EC, Rai RP, Edelman EJ, Fiellin DA, Gibert C, Gordon KS, Huang W, Justice A, Marconi VC, Rimland D, Perkins MM.

AIDS Behav. 2018 Jul;22(7):2381. doi: 10.1007/s10461-018-2074-9.


Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV.

Triplette M, Justice A, Attia EF, Tate J, Brown ST, Goetz MB, Kim JW, Rodriguez-Barradas MC, Hoo GWS, Wongtrakool C, Akgün K, Crothers K.

AIDS. 2018 Feb 20;32(4):487-493. doi: 10.1097/QAD.0000000000001701.


Increased Echocardiographic Pulmonary Pressure in HIV-infected and -uninfected Individuals in the Veterans Aging Cohort Study.

Brittain EL, Duncan MS, Chang J, Patterson OV, DuVall SL, Brandt CA, So-Armah KA, Goetz M, Akgun K, Crothers K, Zola C, Kim J, Gibert C, Pisani M, Morris A, Hsue P, Tindle HA, Justice A, Freiberg M.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):923-932. doi: 10.1164/rccm.201708-1555OC.

Supplemental Content

Loading ...
Support Center